Dacomitinib (D) Versus Erlotinib (E) in Patients (pt) with EGFR-mutated (mu) Advanced Non-small Cell Lung Cancer (NSCLC): Analyses from a Randomized, Phase 2 Trial

被引：0
|
作者：
Ramalingam, S. [1 ]
Blackhall, F. [2 ]
Rosell, R. [3 ]
Mok, T. [4 ]
Boyer, M. [5 ]
Liang, J. [6 ]
O'Connell, J. [6 ]
Wang, T. [6 ]
Taylor, I. [6 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Christie Hosp, Manchester, Lancs, England
[3] Catalan Inst Oncol, Barcelona, Spain
[4] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China
[5] Sydney Canc Ctr, Camperdown, NSW, Australia
[6] Pfizer Oncol, Groton, CT USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S203 / S203
页数：1
相关论文
共 50 条
  • [41] Randomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
    Sequist, L.
    Gray, J.
    Harb, W.
    Doebele, R.
    Modiano, M.
    Jackman, D.
    Baggstrom, M.
    Atmaca, A.
    Felip, E.
    Provencio, M.
    Cobo Dols, M.
    Adiwijaya, B.
    Kuesters, G.
    Kamoun, W.
    Andreas, K.
    Pipas, J.
    Santillana, S.
    Cho, B. C.
    Park, K.
    Shepherd, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S596 - S596
  • [42] Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib
    Sorensen, Steffen Filskov
    Demuth, Christina
    Weber, Britta
    Sorensen, Boe Sandahl
    Meldgaard, Peter
    LUNG CANCER, 2016, 100 : 77 - 84
  • [43] EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) AND CORRELATION WITH SENSITIVITY TO ERLOTINIB
    Ricciardi, S.
    Tedesco, B.
    Migliorino, M. R.
    Graziano, P.
    Leone, A.
    Di Salvia, M.
    Capodaglio, V.
    Condo, S.
    De Santis, S.
    De Marinis, F.
    EJC SUPPLEMENTS, 2008, 6 (14): : 134 - 134
  • [44] Intracranial activity of dacomitinib in treatment naive advanced EGFR mutated non-small cell lung cancer (NSCLC): Prespecified subgroup analysis of the ATORG-003 trial
    Tan, A.
    Kim, D-W.
    Baisamut , T.
    Ni, L. Yueh
    Ho, G. F.
    Tho, L. M.
    Prasongsook, N.
    Lee, S.
    Mok, T. S. K.
    Tan, D. S. W.
    Loong, H. H. F.
    ANNALS OF ONCOLOGY, 2022, 33 : S1582 - S1583
  • [45] Pharmacokinetics of edoxaban in EGFR-mutated non-small cell lung cancer patients with venous thromboembolism
    Hotta, Takamasa
    Tsubata, Yukari
    Hamai, Kosuke
    Tanino, Akari
    Kobayashi, Misato
    Nakamura, Atsushi
    Sugisaka, Jun
    Hongoh, Masafumi
    Ishihara, Noriyuki
    Ishikawa, Nobuhisa
    Yamasaki, Masahiro
    Fujitaka, Kazunori
    Kubota, Tetsuya
    Nishimura, Nobuhiro
    Isobe, Takeshi
    RESPIRATORY INVESTIGATION, 2021, 59 (03) : 327 - 334
  • [46] RNA Sequencing to Characterize Pathways in Patients with EGFR-mutated Non-Small Cell Lung Cancer
    Yun, N. K.
    Pope, C.
    Cagin, K. M.
    Naqib, A.
    Borgia, J. A.
    Fidler, M. J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S449 - S449
  • [47] Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
    Fu, Kai
    Xie, Fachao
    Wang, Fang
    Fu, Liwu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [48] Kinase Fusions as Recurrent Mechanisms of Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Ou, S.
    Klempner, S.
    Creelan, B.
    Hsieh, W. S.
    Costin, D.
    Stephens, P. J.
    Ross, J.
    Miller, V.
    Ali, S.
    Schrock, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1848 - S1848
  • [49] Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
    Kai Fu
    Fachao Xie
    Fang Wang
    Liwu Fu
    Journal of Hematology & Oncology, 15
  • [50] Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial
    Chmielecki, Juliann
    Mok, Tony
    Wu, Yi-Long
    Han, Ji-Youn
    Ahn, Myung-Ju
    Ramalingam, Suresh S.
    John, Thomas
    Okamoto, Isamu
    Yang, James Chih-Hsin
    Shepherd, Frances A.
    Bulusu, Krishna C.
    Laus, Gianluca
    Collins, Barbara
    Barrett, J. Carl
    Hartmaier, Ryan J.
    Papadimitrakopoulou, Vassiliki
    NATURE COMMUNICATIONS, 2023, 14 (01)
12345